Clinical trials
Triple Negative Breast Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 3 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 6 |
| 2017 | 11 |
| 2018 | 7 |
| 2019 | 10 |
| 2020 | 14 |
| 2021 | 10 |
| 2022 | 10 |
| 2023 | 5 |
| 2024 | 16 |
| 2025 | 12 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Recruiting | 30 |
| Active, not recruiting | 28 |
| Terminated | 17 |
| Unknown status | 5 |
| Not yet recruiting | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 12 |
| Institut Curie | 9 |
| UNICANCER | 8 |
| Merck Sharp & Dohme LLC | 7 |
| Hoffmann-La Roche | 6 |
| AbbVie | 5 |
| Eli Lilly and Company | 5 |
| AstraZeneca | 4 |
| Bristol-Myers Squibb | 4 |
| Gilead Sciences | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 122 |
| Carcinoma, Non-Small-Cell Lung | 37 |
| Breast Neoplasms | 36 |
| Ovarian Neoplasms | 20 |
| Melanoma | 17 |
| Neoplasms | 17 |
| Neoplasm Metastasis | 16 |
| Uterine Cervical Neoplasms | 16 |
| Colorectal Neoplasms | 15 |
| Squamous Cell Carcinoma of Head and Neck | 15 |
Trials
Showing 26 to 50 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.